Pharmacists in Nebraska City, Nebraska


13 Pharmacists found in Nebraska City
female pharmacist

Dr. Anna Joy Trosper, PHARMD, RPH


Pharmacist
2101 S 11th St, Nebraska City, NE 68410
402-874-9093     402-874-9098

female pharmacist

Anna Carnazzo


Pharmacist
502 S 11th St, Nebraska City, NE 68410
402-290-1653    

male pharmacist

Benjamin Ralph Grote, RPH


Pharmacist
502 S 11th St, Nebraska City, NE 68410
402-873-1012     402-893-1029



female pharmacist

Mrs. Karen Vogel, PHARM.D.


Pharmacist
502 S 11th St, Nebraska City, NE 68410
402-873-1012    

male pharmacist

Matthew James Hower, PHARMD


Pharmacist
1821 S 11th St, Nebraska City, NE 68410
402-873-3397     402-873-3825

female pharmacist

Dr. Molly Albus, PHARMD


Pharmacist
1301 Grundman Blvd, Nebraska City, NE 68410
402-873-8939    

female pharmacist

Nicki Smith


Pharmacist
824 Central Ave, Nebraska City, NE 68410
402-873-3397    

male pharmacist

Phillip Gerard Wright


Pharmacist
2101 S 11th St, Nebraska City, NE 68410
402-874-9093    

male pharmacist

Robert Moser


Pharmacist
824 Central Ave, Nebraska City, NE 68410
402-873-3397    

male pharmacist

Ryan Pieper, PHARMD


Pharmacist
502 S 11th St, Nebraska City, NE 68410
402-873-1012    

female pharmacist

Susanne Joyce Frerichs, PHARMD, RPH


Pharmacist
2101 S 11th St, Nebraska City, NE 68410
402-874-9093     402-874-9098

male pharmacist

Timothy Muntz


Pharmacist
502 S 11th St, Nebraska City, NE 68410
816-254-8748     816-833-1726

male pharmacist

Zachary Ray Kaster, PHARMD.


Pharmacist
1821 S 11th St, Nebraska City, NE 68410
402-873-3397    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.